The use of the microplate alamar blue assay (MABA) to assess the susceptibility of Mycobacterium lepraemurium to anti-leprosy and other drugs

Journal of Infection and Chemotherapy

Volumn 18, Issue 5, 2012, Pages 652-661

  Mendoza Aguilar, Melby ^a   Almaguer Villagrán, Laura ^a   Jiménez Arellanes, Adelina ^b   Arce Paredes, Patricia ^a   Cid Gutiérrez, José Luis ^a   Rojas Espinosa, Oscar ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b HOSPITAL DE PEDIATRÍA   (Mexico)

Author keywords

Microplatealamar blue assay (MABA); Murine leprosy; Mycobacterium lepraemurium

Indexed keywords

CLOFAZIMINE; DAPSONE; ETHIONAMIDE; KANAMYCIN; NEOLIGNAN; OLEANOLIC ACID; RIFAMPICIN; SITOSTEROL; STREPTOMYCIN; THIOACETAZONE; URSOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; BACTERIAL VIABILITY; BACTERIUM CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANALYSIS; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LEPROSY; MICROPLATE ALAMAR BLUE ASSAY; MOUSE; MYCOBACTERIUM LEPRAEMURIUM; NONHUMAN;

EID: 84871378251     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0387-6     Document Type: Article

References (40)

1. Rojas-Espinosa O. Murine leprosy revisited. In: Tomioka H, editor. Current topics on the profiles of host immunological response to mycobacterial infections. Special Immunology Review Book. Trivandrum, India: Research Signpost; 2009. 97-140. ISBN:978-81-308-0362-3
2. Rojas-Espinosa O, Lovik M. Mycobacterial infections in domestic and wild animals: Mycobacterium leprae and Mycobacterium lepraemurium. Rev Sci Tech. 2001;20:219-51.
3. Ha DK, Lawton JW, Collins RJ. A histopathological study of pulmonary infection of mice with Mycobacterium lepraemurium. J Comp Pathol. 1988;99:421-9.
4. Krakower C, Gonzalez LM. Spontaneous leprosy in a mouse. Science. 1937;86:617-8.
5. Vaishnavi C, Ganguly NK, Kumar B, Chakravarti R, Kaur S. Histopathological study of skin, nose, ear and tail in experimental leprosy. Jpn J Exp Med. 1989;59:79-84.
6. Rojas-Espinosa O, Oltra A, Arce P, Mendez P, Gonzalez-Mendoza A. Glomerular immunoglobulin deposition in the absence of tissue damage in murine leprosy. Int J Lepr Other Mycobact Dis. 1989;57:879-82.
7. Rojas-Espinosa O, Reyes-Maldonado E. Renal alterations in murine leprosy. Int J Lepr Other Mycobact Dis. 1991;59:652-5.
8. Rojas Espinosa O, Becerril-Villanueva E, Wek-Rodríguez K, Arce-Paredes P, Reyes-Maldonado E. Palsy of the rear limbs in Mycobacterium lepraemurium-infected mice results from bone damage and not from nerve involvement. Clin Exp Immunol. 2005;140:436-42.
9. Kawaguchi Y. Classification of mouse leprosy. Jpn J Exp Med. 1959;29:651-63.
10. Roggero E, Bottasso O, Morini J. Characterization of experimental infection with Mycobacterium lepraemurium in 2 strains of mice. Rev Argent Microbiol. 1988;20:26-35.
11. Closs O. Experimental murine leprosy: growth of Mycobacterium lepraemurium in C3H and C57BL mice after footpad inoculation. Infect Immun. 1975;12:480-9.
12. Closs O, Haugen OA. Experimental murine leprosy. 4. The gross appearance and microscopic features of the local infiltrate after subcutaneous inoculation of C3H and C57/BL mice with Mycobacterium lepraemurium. Acta Pathol Microbiol Scand (A). 1975;83:59-68.
13. Lovik M, Closs O. Local reactivity, local resistance and systemic dissemination in Mycobacterium lepraemurium (MLM) infection. Clin Exp Immunol. 1989;75:461-5.
14. Silbaq F, Mor N, Levy L, Bercovier H. The disease of CBA and Balb/c mice that follows inoculation of a small number of Mycobacterium lepraemurium into the hind footpad. Int J Lepr Other Mycobact Dis. 1990;58:681-9.
15. Silbaq F, Levy L, Bercovier H. Doubling time of Mycobacterium lepraemurium in mouse footpads. Res Microbiol. 1989;140: 43-50.
16. Azuma I, Yamamura Y, Tanaka Y, Kosaka K, Mori T. Cell wall of Mycobacterium lepraemurium strain Hawaii. J Bacteriol. 1973;113:515-8.
17. Prabhakaran K, Harris EB, Kirchheimer WF. Binding of 14Clabeled DOPA by Mycobacterium leprae in vitro. Int J Lepr Other Mycobact Dis. 1976;44:58-64.
18. Draper P (1980) Report of the fifth meeting of the Scientific Working Group on the Immunology of Leprosy, Geneva, 24-26 June, 1980, TDR/IMMLEP-SGW 5/80.3.
19. Jarnagin JL, Luchsinger DW. The use of fluorescein diacetate and ethidium bromide as a stain for evaluating viability of mycobacteria. Stain Technol. 1980;55:253-8.
20. Jimenez A, Meckes M, Alvarez V, Torres J, Parra R. Secondary metabolites from Chamaedora tepejilote (Palmae) are active against Mycobacterium tuberculosis. Phytother Res. 2005;19:320-2.
21. Jiménez-Arellanes A, Meckes M, Torres J, Luna J. Antimycobacterial triterpenoids from Lantana hispida (Verbenaceae). J Ethnopharmacol. 2007;111:202-5.
22. Silva-Miranda M, Wek-Rodriguez K, Martinez-Cordero E, Rojas-Espinosa O. Expression of cyclooxygenase-2, alpha 1-acidglycoprotein and inducible nitric oxide synthase in the developing lesions of murine leprosy. Int J Exp Pathol. 2006;87:485-94.
23. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;26:497-509.
24. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193:265-70.
25. Palomino JC, Martin A, Camacho M, Guerra H, Swings J, Portaels F. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2002;46:2720-2.
26. Franzblau SG, Witzig RS, McLaughlin JC, Torres P, Madico G, Hernandez A, et al. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate alamar blue assay. J Clin Microbiol. 1998;36:362-6.
27. Vanitha JD, Paramasivan CN. Evaluation of microplate alamar blue assay for drug susceptibility testing of Mycobacterium avium complex isolates. Diagn Microbiol Infect Dis. 2004;49:179-82.
28. Webster D, Lee TDG, Moore J, Manning T, Kunimoto D, Le-Blanc D, et al. Antimycobacterial screening of traditional medicinal plants using the microplate resazurin assay. Can J Microbiol. 2010;56:487-94.
29. Collins L, Franzblau SG. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother. 1997;41:1004-9.
30. Bastian I, Rigouts L, Palomino JC, Portaels F. Kanamycin susceptibility testing of Mycobacterium tuberculosis using mycobacterium growth indicator tube and colorimetric method. Antimicrob Agents Chemother. 2001;45:1934-6.
31. Martin A, Camacho M, Portaels F, Palomino JC. Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob Agents Chemother. 2003;47:3616-9.
32. Reis RS, Neves I Jr., Lourenco SL, Fonseca LS, Lourenco MC. Comparison of flow cytometric and Alamar Blue tests with the proportional method for testing susceptibility of Mycobacterium tuberculosis to rifampin and isoniazid. J Clin Microbiol. 2004;42:2247-8.
33. Franzblau S. A rapid, microplate-based assay for evaluating the activity of drugs against Mycobacterium leprae, employing the reduction of alamar blue. Lepr Rev. 2000;71(Suppl):S74-6.
34. Pogorelov VN. Effectiveness of kanamycin in rat leprosy. Antibiotiki. 1964;45:1096-8.
35. Mauri AC, Hadler WA, Carvalho CM. Chemotherapy of leprosy. 1. Effect of 4,4-diaminodiphenylsulfone in rat leprosy. Rev Bras Leprol. 1951;19:85-116.
36. Cruickshank JC. Isoniazid in the treatment of rat leprosy. Lancet. 1954;267:528-9.
37. Mudrow-Reichenow L. Rat leprosy in therapeutic testing. Z Tropenmed Parasitol. 1955;6:460-72.
38. Fegeler F. The favourable effect of kanamycin in experimental rat leprosy. Z Tropenmed Parasitol. 1959;10:447-9.
39. Camargo EE, Larson SM, Tepper BS, Wagner HN Jr. A radiometric method for predicting effectiveness of chemotherapeutic agents in murine leprosy. Int J Lepr Other Mycobact Dis. 1975; 43:234-8.
40. Portaels F, Pattyn SR, Francken A. In vitro sensitivity of Mycobacterium lepraemurium for antimycobacterial drugs. Arzneimittelforschung. 1982;32:1123-4.